OOIR: Observatory of International Research

Papers

(The H4-Index of Marine Drugs is 53. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Seaweed Phenolics: From Extraction to Applications	232
Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study	224
Fish Waste: From Problem to Valuable Resource	191
Seaweeds as a Functional Ingredient for a Healthy Diet	184
Marine Collagen from Alternative and Sustainable Sources: Extraction, Processing and Applications	165
Preparation of Alginate-Based Biomaterials and Their Applications in Biomedicine	162
Carrageenan: Drug Delivery Systems and Other Biomedical Applications	162
Advanced Technologies for the Extraction of Marine Brown Algal Polysaccharides	145
Research Strategies to Develop Environmentally Friendly Marine Antifouling Coatings	123
Exploring Ultrasound, Microwave and Ultrasound–Microwave Assisted Extraction Technologies to Increase the Extraction of Bioactive Compounds and Antioxidants from Brown Macroalgae	119
Mechanisms of Bioactivities of Fucoidan from the Brown Seaweed Fucus vesiculosus L. of the Barents Sea	114
Astaxanthin and other Nutrients from Haematococcus pluvialis—Multifunctional Applications	94
Xanthophylls from the Sea: Algae as Source of Bioactive Carotenoids	92
Optimisation of Ultrasound Frequency, Extraction Time and Solvent for the Recovery of Polyphenols, Phlorotannins and Associated Antioxidant Activity from Brown Seaweeds	89
Fishery Wastes as a Yet Undiscovered Treasure from the Sea: Biomolecules Sources, Extraction Methods and Valorization	86
Recent Advances in Molecular Docking for the Research and Discovery of Potential Marine Drugs	85
Structures, Properties and Applications of Alginates	82
Cosmetic, Biomedical and Pharmaceutical Applications of Fish Gelatin/Hydrolysates	79
LC-ESI-QTOF-MS/MS Characterization of Seaweed Phenolics and Their Antioxidant Potential	78
Genome Mining as New Challenge in Natural Products Discovery	78
Antioxidant Compounds from Microalgae: A Review	77
Comprehensive Assessment of Nile Tilapia Skin (Oreochromis niloticus) Collagen Hydrogels for Wound Dressings	77
Fucoidan Characterization: Determination of Purity and Physicochemical and Chemical Properties	75
Microalgae n-3 PUFAs Production and Use in Food and Feed Industries	74
Functional and Bioactive Properties of Peptides Derived from Marine Side Streams	71

Algae Metabolites in Cosmeceutical: An Overview of Current Applications and Challenges	71
Recent Advances in Marine-Based Nutraceuticals and Their Health Benefits	71
Impact of Astaxanthin on Diabetes Pathogenesis and Chronic Complications	69
Enzyme-Assisted Fucoidan Extraction from Brown Macroalgae Fucus distichus subsp. evanescens and Saccharina latissima	68
Marine Collagen: A Promising Biomaterial for Wound Healing, Skin Anti-Aging, and Bone Regeneration	68
Phytochemical and Potential Properties of Seaweeds and Their Recent Applications: A Review	66
Cyanobacteria—From the Oceans to the Potential Biotechnological and Biomedical Applications	65
Brown Algae Carbohydrates: Structures, Pharmaceutical Properties, and Research Challenges	64
Microalgae Encapsulation Systems for Food, Pharmaceutical and Cosmetics Applications	64
Northern Sea Cucumber (Cucumaria frondosa): A Potential Candidate for Functional Food, Nutraceutical, and Pharmaceutical Sector	64
Progress in Modern Marine Biomaterials Research	64
An Overview to the Health Benefits of Seaweeds Consumption	63
Clinical Applications of Astaxanthin in the Treatment of Ocular Diseases: Emerging Insights	63
Antioxidant Peptides from the Protein Hydrolysate of Monkfish (Lophius litulon) Muscle: Purification, Identification, and Cytoprotective Function on HepG2 Cells Damage by H2O2	62
Recent Advances in Astaxanthin Micro/Nanoencapsulation to Improve Its Stability and Functionality as a Food Ingredient	59
Analysis of Scientific Research Driving Microalgae Market Opportunities in Europe	59
Neuroprotective Potentials of Marine Algae and Their Bioactive Metabolites: Pharmacological Insights and Therapeutic Advances	59
Anti-Inflammatory and Anticancer Effects of Microalgal Carotenoids	58
The Application of Mucoadhesive Chitosan Nanoparticles in Nasal Drug Delivery	58
Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes	58
An Overview of Potential Seaweed-Derived Bioactive Compounds for Pharmaceutical Applications	58
Chitin and Chitosan: Prospective Biomedical Applications in Drug Delivery, Cancer Treatment, and Wound Healing	57
Pheophorbide a: State of the Art	56
Carotenoid Production from Microalgae: Biosynthesis, Salinity Responses and Novel Biotechnologies	56
Marine Actinomycetes, New Sources of Biotechnological Products	55
Bioactive Properties of Marine Phenolics	55
The Comparative Analysis of Antiviral Activity of Native and Modified Fucoidans from Brown Algae Fucus evanescens In Vitro and In Vivo	54
Emerging Technologies for the Extraction of Marine Phenolics: Opportunities and Challenges	54
Novel Antioxidant Collagen Peptides of Siberian Sturgeon (Acipenserbaerii) Cartilages: The Preparation, Characterization, and Cytoprotection of H2O2-Damaged Human Umbilical Vein Endothelial Cells (HUV	53
Microalgae as Contributors to Produce Biopolymers	53
Microalgae as Sustainable Bio-Factories of Healthy Lipids: Evaluating Fatty Acid Content and Antioxidant Activity	53
Algae-Derived Bioactive Compounds with Anti-Lung Cancer Potential	53
Marine Cyanobacteria and Microalgae Metabolites—A Rich Source of Potential Anticancer Drugs	53
Marine Algae-Derived Bioactive Compounds: A New Wave of Nanodrugs?	53
Fish-Based Bioactives as Potent Nutraceuticals: Exploring the Therapeutic Perspective of Sustainable Food from the Sea	53